Search results for "sero-epidemiology"

showing 2 items of 2 documents

European Sero-Epidemiology Network 2: standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparations.

2008

A standardisation process, already developed during the earlier European Sero-Epidemiology Network (ESEN) project, was employed with a more robust algorithm to harmonise results of pertussis serological assays performed in 12 European and non-European countries. Initially, results from each country's own assay were compared with those obtained at the reference laboratory by means of an in-house pertussis toxin (PT)-based ELISA: seven countries used in-house or commercial PT-ELISAs; the other countries used assays based on Bordetella pertussis whole cell extracts (WCE) (three countries) or on combined PT-FHA (filamentous haemagglutinin) antigenic preparations (two countries). The WCE assays,…

ESEN (European Sero-Epidemiology Network) Pertussis sero-epidemiology Immunoassay standardisation Pertussis antigenic preparationsBordetella pertussisSettore MED/07 - Microbiologia E Microbiologia ClinicaWhooping CoughPertussis toxinBordetella pertussisSerologyAntigenmedicineSero epidemiologyHumansLow correlationWhooping coughImmunoassayPertussis VaccineAntigens BacterialGeneral VeterinaryGeneral Immunology and Microbiologymedicine.diagnostic_testbiologybusiness.industryPublic Health Environmental and Occupational Healthmedicine.diseasebiology.organism_classificationVirologyAntibodies BacterialEuropeInfectious DiseasesImmunoassayImmunologyCalibrationMolecular MedicinebusinessVaccine
researchProduct

Sero-Epidemiological Study of Varicella in the Italian General Population.

2023

The aim of this study was to analyze the seroprevalence of varicella in Italy and to evaluate the impact of varicella vaccination, which has been mandatory for newborns since 2017. The levels of VZV-specific IgG antibodies were determined by the ELISA method in residual serum samples obtained from subjects aged between 6 and 64 years and residing in 13 Italian regions. Overall, 3746 serum samples were collected in the years 2019 and 2020. The overall seroprevalence was 91.6% (89.9% in males and 93.3% in females; p = 0.0002). Seroprevalence showed an increasing trend (p < 0.0001) starting in the younger age groups: 6–9 years: 84.1%; 10–14 years: 88.7%; 15–19 years: 89.3%…

PharmacologyInfectious DiseasesvaricellaItaly; general population; immunization; sero-epidemiology; varicellaItalysero-epidemiologyDrug DiscoveryImmunologyPharmacology (medical)immunizationSettore MED/42 - Igiene Generale E Applicatavaricella sero-epidemiology Italy general population immunizationgeneral population
researchProduct